Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy .

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.

Pfizer Inc. PFE

• Dividend Yield: 6.38%
• Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating with a price target of $45 on April 5, 2024. This analyst has an accuracy rate of 64%.
• Guggenheim analyst Vamil Divan initiated coverage on the stock with a Buy rating and a price target of $36 on Feb. 23, 2024. This analyst has an accuracy rate of 77%.
• Recent News: Pfizer recently released top-line immunogenicity and safety data from the ongoing pivotal Phase 3 MONeT trial,evaluating a single dose of Abrysvo versus placebo in adults 18 to 59 years of age at risk of developing severe respiratory syncytial virus (RSV)-associated lower respiratory tract disease (LRTD).

GSK plc GSK

• Dividend Yield: 3.61%
• BMO Capital analyst Etzer Darout maintained an Outperform rating and cut the price target from $82 to $80 on Feb. 12, 2024. This analyst has an accuracy rate of 60%.
• Morgan Stanley analyst Mark Purcell initiated coverage on the stock with an Overweight rating and a price target of $85 on Jan. 23, 2024. This analyst has an accuracy rate of 65%.
• Recent News: CureVac released interim data on Thursday, April 4, from studies it conducted on its seasonal influenza vaccine candidate. The study is part of a collaboration with GSK Plc.

Patterson Companies, Inc. PDCO

• Dividend Yield: 4.05%
• Morgan Stanley analyst Erin Wright maintained an Equal-Weight rating and slashed the price target from $38 to $35 on Nov. 30, 2023. This analyst has an accuracy rate of 78%.
• Stifel analyst Jonathan Block reiterated a Hold rating with a price target of $32 on Nov. 28, 2023. This analyst has an accuracy rate of 79%.
• Recent News: On March 11, Patterson Companies approved a $500 million stock buyback and declared a quarterly dividend of 26 cents per share.

Read More: Jim Cramer Says WESCO International Is A Buy, Recommends Buying This Stock Under $20